Your browser of choice has not been tested for use with Barchart.com. If you have issues, please download one of the browsers listed here.
Less than $10/month! View ALL results for your Stocks, ETFs and Funds Screeners with Barchart Plus. FREE 30 Day Trial
Stocks | Futures | Watchlist | News | More
or

Atricure Inc (ATRC)

Atricure Inc (ATRC)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [NASDAQ]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] by (Cboe BZX)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [NASDAQ]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] [[ item.lastPriceExt ]] [[ item.priceChangeExt ]] ([[ item.percentChangeExt ]]) [[ item.tradeTimeExt ]]
News & Headlines for [[ item.sessionDateDisplayLong ]]
AtriCure: Q2 Earnings Snapshot

AtriCure: Q2 Earnings Snapshot

ATRC : 28.81 (+2.93%)
AtriCure: Q1 Earnings Snapshot

AtriCure: Q1 Earnings Snapshot

ATRC : 28.81 (+2.93%)
AtriCure: Q4 Earnings Snapshot

AtriCure: Q4 Earnings Snapshot

ATRC : 28.81 (+2.93%)
AtriCure: Q3 Earnings Snapshot

AtriCure: Q3 Earnings Snapshot

ATRC : 28.81 (+2.93%)
AtriCure: Q2 Earnings Snapshot

AtriCure: Q2 Earnings Snapshot

ATRC : 28.81 (+2.93%)
AtriCure: Q1 Earnings Snapshot

AtriCure: Q1 Earnings Snapshot

ATRC : 28.81 (+2.93%)
AtriCure Reports First Quarter 2023 Financial Results

AtriCure, Inc. ( Nasdaq: ATRC ), a leading innovator in surgical treatments and therapies for atrial fibrillation (Afib), left atrial appendage (LAA) management and post-operative pain management, today...

ATRC : 28.81 (+2.93%)
AtriCure to Participate in the 2023 Bank of America Health Care Conference and Host a Cryo Nerve Block Therapy Investor Education Webcast

AtriCure, Inc. ( Nasdaq: ATRC ), a leading innovator in surgical treatments and therapies for atrial fibrillation (Afib), left atrial appendage (LAA) management and post-operative pain management, today...

ATRC : 28.81 (+2.93%)
AtriCure to Announce First Quarter 2023 Financial Results

AtriCure, Inc. ( Nasdaq: ATRC ), a leading innovator in surgical treatments and therapies for atrial fibrillation (Afib), left atrial appendage (LAA) management, and post-operative pain management, today...

ATRC : 28.81 (+2.93%)
AtriCure to Participate in the 22nd Annual Needham Virtual Healthcare Conference

AtriCure, Inc. ( Nasdaq: ATRC ), a leading innovator in surgical treatments and therapies for atrial fibrillation (Afib), left atrial appendage (LAA) management, and post-operative pain management, today...

ATRC : 28.81 (+2.93%)

Barchart Exclusives

How Surging AI Demand Could Drive This Dividend Stock Higher
Eaton, a diversified power management company, is poised to benefit from the surging demand for AI-driven data centers, with its innovative power solutions and strong dividend growth making it an attractive investment opportunity. Read more
Want to use this as
your default charts setting?
Save this setup as a Chart Templates
Switch the Market flag
for targeted data from your country of choice.
Open the menu and switch the
Market flag for targeted data from your country of choice.
Want Streaming Chart Updates?
Switch your Site Preferences
to use Interactive Charts
Need More Chart Options?
Right-click on the chart to open the Interactive Chart menu.
Use your up/down arrows to move through the symbols.

Free Barchart Webinar